Study ID: MSA-RAS-202 | 2009-014644-11
Study Title
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)
Teva Identifier
- MSA-RAS-202 | 2009-014644-11
ClinicalTrials.gov Identifier
- NCT00977665
Study Status
- Completed
Trial Condition(s)
- Multiple System Atrophy
Interventions
- Drug: rasagiline mesylate | Drug: placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 30 Years and older
Trial Duration
- 12/01/2009 - 10/01/2011
Phase
- Phase 2
Study Type
Interventional